Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-96-000098
Filing Date
1996-04-01
Accepted
1996-04-01 00:00:00
Documents
13
Period of Report
1995-12-25
SROs
AMEX

Document Format Files

Seq Description Document Type Size
1 10-K 275976
2 TERMINATION AND CONSULTING AGREEMENT EX-10.7 19836
3 IVAX CORP. U.S. INCENTIVE BONUS PLAN EX-10.8 7720
4 AMEND. 4 TO REVOLVING CREDIT AND REIMBURSEMENT AGR EX-10.19 12963
5 AMEND. 5 TO REVOLVING CREDIT AND REIMBURSEMENT AGR EX-10.20 13454
6 COMPUTATION OF EARNINGS PER SHARE EX-11.1 4752
7 SUBSIDIARIES OF IVAX CORPORATION EX-21.1 5078
8 CONSENT OF ARTHUR ANDERSEN LLP EX-23.1 532
9 CONSENT OF ERNST & YOUNG LLP EX-23.2 678
10 CONSENT OF COOPERS & LYBRAND L.L.P. EX-23.3 830
11 ART. 5 FDS FOR 1995 10-K EX-27 2423
12 REPORT OF ERNST & YOUNG LLP EX-99.1 1699
13 REPORT OF COOPERS & LYBRAND EX-99.2 2599
  Complete submission text file 0000950170-96-000098.txt   351453
Mailing Address
Business Address 8800 NW 36TH ST MIAMI FL 33178 3055902200
IVAX CORP /DE (Filer) CIK: 0000772197 (see all company filings)

EIN.: 161003559 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-09623 | Film No.: 96543168
SIC: 2834 Pharmaceutical Preparations